Salta al contenuto principale
Passa alla visualizzazione normale.

SALVATORE PETTA

Curriculum e ricerca

Insegnamenti

Anno accademico Codice della materia Nome della materia CFU Corso di studi
2019/2020 03550 GASTROENTEROLOGIA (MODULO) 3 MEDICINA E CHIRURGIA
2019/2020 87434 GASTROENTEROLOGIA II (MODULO) 3 DIETISTICA (ABILITANTE ALLA PROFESSIONE SANITARIA DI DIETISTA)

Pubblicazioni

Data Titolo Tipologia Scheda
2019 Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons with HIV infection and Compensated Advanced Chronic Liver Disease Articolo in rivista Vai
2019 Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data Articolo in rivista Vai
2019 Role of myeloid-epithelial-reproductive tyrosine kinase and macrophage polarization in the progression of atherosclerotic lesions associated with nonalcoholic fatty liver disease Articolo in rivista Vai
2019 Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV-monoinfected patients Articolo in rivista Vai
2019 PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients Articolo in rivista Vai
2019 Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity Articolo in rivista Vai
2019 Liver stiffness quantification in patients with non-alcoholic steatohepatitis: comparison of shear wave elastography and transient elastography with liver biopsy correlation Proceedings (TIPOLOGIA NON ATTIVA) Vai
2019 Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis Articolo in rivista Vai
2019 Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals Articolo in rivista Vai
2019 Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients Proceedings (TIPOLOGIA NON ATTIVA) Vai
2019 Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation Articolo in rivista Vai
2019 Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients with Nonalcoholic Fatty Liver Disease Articolo in rivista Vai
2019 Aminopyrine breath test predicts liver-related events and death in HCV-related cirrhosis on SVR after DAA therapy Articolo in rivista Vai
2019 Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease Articolo in rivista Vai
2019 Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study) Articolo in rivista Vai
2019 qFIBS: A Novel Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis Articolo in rivista Vai
2019 The burden of hepatocellular carcinoma in non-alcoholic fatty liver disease: Screening issue and future perspectives Articolo in rivista Vai
2019 Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? the REAL Experience Articolo in rivista Vai
2019 Pharmacological therapy of non-alcoholic fatty liver disease: What drugs are available now and future perspectives Articolo in rivista Vai
2019 Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease Articolo in rivista Vai
2019 Development and Validation of Hepamet Fibrosis Scoring System A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis Articolo in rivista Vai
2019 Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation Articolo in rivista Vai
2019 Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease Articolo in rivista Vai
2019 Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Articolo in rivista Vai
2018 Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis Articolo in rivista Vai
2018 Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents Articolo in rivista Vai
2018 The course of oesophagogastric varices in patients with cirrhosis after DAA-induced HCV clearance Proceedings (TIPOLOGIA NON ATTIVA) Vai
2018 FibroScan Detects Cardiovascular Damage in Patients With NAFLD Abstract in rivista Vai
2018 A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B Articolo in rivista Vai
2018 Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort Poster pubblicato in rivista Vai
2018 Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030 Articolo in rivista Vai
2018 Expert opinion on managing chronic HCV in patients with cardiovascular disease Articolo in rivista Vai
2018 Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN) Articolo in rivista Vai
2018 An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers Articolo in rivista Vai
2018 Antidiabetic drugs in NAFLD: The accomplishment of two goals at once? Articolo in rivista Vai
2018 Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease Articolo in rivista Vai
2018 Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study Articolo in rivista Vai
2018 Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. Articolo in rivista Vai
2018 Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population Articolo in rivista Vai
2018 Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis Articolo in rivista Vai
2018 Is global elimination of HCV realistic? Articolo in rivista Vai
2018 Liver and statins: a critical appraisal of the evidence Articolo in rivista Vai
2018 L’insulino-resistenza è il principale fattore indipendente correlato con l’aumentato rischio metabolico nelle donne affette da PCOS Proceedings (TIPOLOGIA NON ATTIVA) Vai
2018 Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents Articolo in rivista Vai
2018 Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis Articolo in rivista Vai
2017 Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV Articolo in rivista Vai
2017 Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study Articolo in rivista Vai
2017 Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma Articolo in rivista Vai
2017 Hepatitis C virus and cardiovascular: A review Articolo in rivista Vai
2017 Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study Articolo in rivista Vai
2017 Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease Articolo in rivista Vai
2017 Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS Articolo in rivista Vai
2017 A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma Articolo in rivista Vai
2017 The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B Articolo in rivista Vai
2017 Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network Articolo in rivista Vai
2017 AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions Articolo in rivista Vai
2017 Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel Articolo in rivista Vai
2017 Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values Articolo in rivista Vai
2017 Evidence-Based Medicine and the Problem of Healthy Volunteers Articolo in rivista Vai
2017 Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study Articolo in rivista Vai
2017 Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study Articolo in rivista Vai
2017 Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity Articolo in rivista Vai
2017 Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease Articolo in rivista Vai
2017 Can we prevent and modify cardiometabolic disorders by controlling HCV infection? Articolo in rivista Vai
2017 Coffee and tea breaks for liver health Articolo in rivista Vai
2017 HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals Articolo in rivista Vai
2017 Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter Articolo in rivista Vai
2017 Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease Articolo in rivista Vai
2017 Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD Articolo in rivista Vai
2017 Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study Articolo in rivista Vai
2017 Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease Articolo in rivista Vai
2017 Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon Articolo in rivista Vai
2017 Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies Articolo in rivista Vai
2017 MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals Articolo in rivista Vai
2017 Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver Articolo in rivista Vai
2017 Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis Articolo in rivista Vai
2016 Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies Articolo in rivista Vai
2016 A "systems medicine" approach to the study of non-alcoholic fatty liver disease Articolo in rivista Vai
2016 The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent Articolo in rivista Vai
2016 Renin-angiotensin system inhibitors, type 2 diabetes and fibrosis progression: An observational study in patients with nonalcoholic fatty liver disease Articolo in rivista Vai
2016 Pathophysiology of non alcoholic fatty liver disease Articolo in rivista Vai
2016 The Presence of White Matter Lesions Is Associated With the Fibrosis Severity of Nonalcoholic Fatty Liver Disease Articolo in rivista Vai
2016 The cheating liver: imaging of focal steatosis and fatty sparing Articolo in rivista Vai
2016 HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels Articolo in rivista Vai
2016 Non-Invasive Assessment of Liver Injury in Non-Alcoholic Fatty Liver Disease: A Review of Literature Articolo in rivista Vai
2016 From current status to optimization of HCV treatment: Recommendations from an expert panel Articolo in rivista Vai
2016 IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection Articolo in rivista Vai
2016 TM6SF2 rs58542926 is not associated with steatosis and fibrosis in largecohort of patients with genotype 1 chronic hepatitis C Articolo in rivista Vai
2016 Impact of virus eradication in patients with compensated hepatitis C virus-related cirrhosis: competing risks and multistate model Abstract in rivista Vai
2015 Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis Articolo in rivista Vai
2015 The rs2294918 E434K variant modulates PNPLA3 expression and liver damage Articolo in rivista Vai
2015 Current and future HCV therapy: Do we still need other anti-HCV drugs? Articolo in rivista Vai
2015 The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease Articolo in rivista Vai
2015 Statin use and non-alcoholic steatohepatitis in at risk individuals Articolo in rivista Vai
2015 Comparison of Histochemical Stainings in Evaluation of Liver Fibrosis and Correlation with Transient Elastography in Chronic Hepatitis Articolo in rivista Vai
2015 The presence of White Matter Lesions is not associated with Non-alcoholic Fatty Liver Disease but with its histological severity Abstract in rivista Vai
2015 Sorafenib for hepatocellular carcinoma: From randomized controlled trials to clinical practice Articolo in rivista Vai
2015 The UCP2 -866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis Articolo in rivista Vai
2015 Genetic background in nonalcoholic fatty liver disease: A comprehensive review Articolo in rivista Vai
2015 Comparison of Histochemical Staining Methods and Correlation with Transient Elastography in Acute Hepatitis. Articolo in rivista Vai
2015 Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease Articolo in rivista Vai
2015 MERTK rs4374383 polymorphism affects the severity of fibrosis in nonalcoholic fatty liver disease Articolo in rivista Vai
2015 Diet, Weight Loss, and Liver Health in NAFLD: Pathophysiology, Evidence and Practice Articolo in rivista Vai
2015 PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C Articolo in rivista Vai
2015 TM6SF2gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease Articolo in rivista Vai
2014 Reply to: “Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients” Recensione in rivista Vai
2014 Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease Articolo in rivista Vai
2014 Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C Articolo in rivista Vai
2014 The Hepatic Expression of Vitamin D Receptor is Inversely Associated with the Severity of Liver Damage in Genotype 1 Chronic Hepatitis C Patients. Articolo in rivista Vai
2014 Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C Articolo in rivista Vai
2014 The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease. Articolo in rivista Vai
2014 Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women Abstract in rivista Vai
2014 Reply to: Is industrial fructose just a marker of an unhealthy dietary pattern? Recensione in rivista Vai
2014 Triple therapy with first-generation Protease Inhibitors for patients with genotype 1 chronic hepatitis C: Recommendations of the Italian Association for the Study of the Liver (AISF) Articolo in rivista Vai
2014 Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C Articolo in rivista Vai
2013 Reply. Articolo in rivista Vai
2013 Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients Articolo in rivista Vai
2013 NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis. Articolo in rivista Vai
2013 Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C Articolo in rivista Vai
2013 Metabolic Factors and Chronic Hepatitis C: A Complex Interplay Articolo in rivista Vai
2013 Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease Articolo in rivista Vai
2013 Antioxidant therapy and drugs interfering with lipid metabolism: could they be effective in NAFLD patients? Articolo in rivista Vai
2013 High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C Articolo in rivista Vai
2013 Chemoprevention for hepatocellular carcinoma: the role of statins Articolo in rivista Vai
2013 Association of vitamin D serum levels and its common genetic determinants with severity of liver fibrosis in genotype 1 chronic hepatitis C patients Proceedings (TIPOLOGIA NON ATTIVA) Vai
2013 Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients Articolo in rivista Vai
2013 Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease Articolo in rivista Vai
2013 PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease Articolo in rivista Vai
2013 Body Mass Index and Liver Stiffness Affect Accuracy of Ultrasonography in Detecting Steatosis in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Articolo in rivista Vai
2013 Update on treatment strategies in patients with non-alcoholic fatty liver disease Articolo in rivista Vai
2013 Reply to: "IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients". Articolo in rivista Vai
2013 Non invasive indexes for the assessment of patients with non-alcoholic fatty liver disease Articolo in rivista Vai
2013 Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance Articolo in rivista Vai
2013 Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma. Articolo in rivista Vai
2013 How to optimize HCV therapy in genotype 1 patients: predictors of response. Articolo in rivista Vai
2013 Cardiovascular diseases and HCV infection: a simple association or more? Articolo in rivista Vai
2012 Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection. Articolo in rivista Vai
2012 Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis. Articolo in rivista Vai
2012 Diagnostic and therapeutical role of vitamin D in chronic hepatitis C virus infection. Articolo in rivista Vai
2012 Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease Articolo in rivista Vai
2012 herapeutic algorithms for chronic hepatitis C in the DAA era during the current economic crisis: whom to treat? How to treat? When to treat? Articolo in rivista Vai
2012 Inverse correlation between plasma oxysterol and LDL-cholesterol levels in hepatitis C virus-infected patients. Articolo in rivista Vai
2012 IL28B and PNPLA3 Polymorphisms Affect Histological Liver Damage in Patients with Non-alcoholic Fatty Liver Disease. Articolo in rivista Vai
2012 Iperuricemia: significato clinico e nuove prospettive di trattamento Proceedings (TIPOLOGIA NON ATTIVA) Vai
2012 Serum γ-glutamyl transferase levels, insulin resistance and liver fibrosis in patients with chronic liver diseases. Articolo in rivista Vai
2012 Chronic hepatitis C and atherosclerosis: A complex pathogenic puzzle. Articolo in rivista Vai
2012 Liver follicular helper T-cells predict the achievement of virological response following interferon-based treatment in HCV-infected patients. Articolo in rivista Vai
2012 Cost-Effectiveness of Boceprevir or Telaprevir for Untreated Patients with Genotype 1 Chronic Hepatitis C Articolo in rivista Vai
2012 Assessment by Fibroscan of fibrosis in nonalcoholic fatty liver disease: XL versus M probe? Articolo in rivista Vai
2012 Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. Articolo in rivista Vai
2012 Insulin resistance and diabetes mellitus in patients with chronic hepatitis C: spectators or actors? Articolo in rivista Vai
2012 Methylenetetrahydrofolate reductase homozygosis and low-density lipoproteins in patients with genotype 1 chronic hepatitis C Articolo in rivista Vai
2012 Reproductive status is associated with the severity of fibrosis in women with hepatitis C Articolo in rivista Vai
2011 LIPIDOMICS OF FATTY LIVER IN NAFLD AND HCV INFECTION: LIVER SPHYNGOLIPIDS AND FATTY ACIDS Proceedings (TIPOLOGIA NON ATTIVA) Vai
2011 TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1. Articolo in rivista Vai
2011 Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. Articolo in rivista Vai
2011 Hyperuricemia in non-alcoholic fatty liver disease: authors' reply. Articolo in rivista Vai
2011 High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis Articolo in rivista Vai
2011 Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. Articolo in rivista Vai
2011 Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Articolo in rivista Vai
2011 FOLLICULAR HELPER T-CELLS POPULATE THE INTRAHEPATIC INFILTRATES OF HCV GENOTYPE-1 CHRONICALLY INFECTED PATIENTS AND PREDICT THE ACHIEVEMENT OF VIROLOGICAL RESPONSE FOLLOWING IFN-BASED TREATMENT Abstract in rivista Vai
2011 Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. Articolo in rivista Vai
2011 LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C Abstract in rivista Vai
2011 Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. Articolo in rivista Vai
2011 Liver follicular helper T-cells in chronic hepatitis C Abstract in rivista Vai
2011 Optimal therapy in hepatitis C virus genotypes 2 and 3 patients. Articolo in rivista Vai
2011 Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations. Articolo in rivista Vai
2011 Is liver stiffness measurement unreliable in obese patients? authors' reply. Articolo in rivista Vai
2010 Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular association. Articolo in rivista Vai
2010 HEPATIC STEATOSIS IS ASSOCIATED WITH SEVERE FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS B Proceedings (TIPOLOGIA NON ATTIVA) Vai
2010 Reply Articolo in rivista Vai
2010 Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C Articolo in rivista Vai
2010 Replay Articolo in rivista Vai
2010 FOLLICULAR HELPER T-CELLS POPULATE THE INTRAHEPATIC INFILTRATES OF HCV GENOTYPE-1 CHRONICALLY INFECTED PATIENTS AND PREDICT THE ACHIEVEMENT OF VIROLOGICAL RESPONSE FOLLOWING IFN-BASED TREATMENT Abstract in rivista Vai
2010 LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C Abstract in rivista Vai
2010 Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. Articolo in rivista Vai
2009 Reply Articolo in rivista Vai
2009 HEPATITIS C AND DIABETES: THE INEVITABLE COINCIDENCE? Articolo in rivista Vai
2009 Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis. Articolo in rivista Vai
2009 Insulin resistance in HCV mono-infected and in HIV/HCV co-infected patients: Looking to the future. Articolo in rivista Vai
2009 Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection Articolo in rivista Vai
2009 Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis Articolo in rivista Vai
2009 Non-alcoholic fatty liver disease pathogenesis: The present and the future Articolo in rivista Vai
2009 Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection Articolo in rivista Vai
2009 Reply Articolo in rivista Vai
2008 Serum BLYS/BAFF levels in acute hepatitis C predict clinical outcome Proceedings (TIPOLOGIA NON ATTIVA) Vai
2008 Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C. Articolo in rivista Vai
2008 Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. Articolo in rivista Vai
2008 751 RETINOL-BINDING PROTEIN 4 (RBP4): A NEW MARKER OF G1 HCV-INDUCED STEATOSIS Articolo in rivista Vai
2008 Retinol-binding protein 4 (RBP4) : a new marker of G1 HCV-induced steatosis Articolo in rivista Vai
2008 Metformina e pioglitazone in soggetti affetti da diabete mellito tipo 2 con steatosi epatica Proceedings (TIPOLOGIA NON ATTIVA) Vai
2008 Hepatic expression of cycloxygenase-2 in non-alcoholic fatty liver disease Proceedings (TIPOLOGIA NON ATTIVA) Vai
2008 Reply Articolo in rivista Vai
2008 Hepatic expression of cyclooxygenase-2 in non alcoholic fatty liver disease Proceedings (TIPOLOGIA NON ATTIVA) Vai
2008 Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis C virus genotype 1. Articolo in rivista Vai
2007 INSULIN RESISTANCE AND SEVERITY OF FIBROSIS IN HCV GENOTYPE 1 CHRONIC HEPATITIS. Proceedings (TIPOLOGIA NON ATTIVA) Vai
2007 The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. Articolo in rivista Vai
2007 STORIA NATURALE DELLA CIRROSI EPATICA Capitolo o Saggio Vai
2007 Virus-related insulin resistance in HCV genotype 1 chronic hepatitis C : a major disease modifier Proceedings (TIPOLOGIA NON ATTIVA) Vai
2005 Il carcinoma dell'esofago Articolo in rivista Vai